KMDA (kamada.com) Prakiraan pendapatan perusahaan

Kamada Ltd - logo grafis emiten KMDA

Amir London's effective management of scaling global sales is driving the growth of Kamada Ltd. (KMDA) share prices. The company's future sales performance demonstrates cyclicity, where the value of 0.27 characterizes this level. Stable demand for plasma antidotes in the US complements the high scientific R&D potential in precision proteins for the therapy of rare pathologies.

KMDA - Pendapatan mangsa ngarep perusahaan Kamada Pharma ing rentang 04.07.2022 - 15.11.2026

Rincian metrik keuangan lan pasar Kamada Pharma (KMDA)

- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
Analisis fundamental perusahaan:kamada.com
Produk mawa merek Kamada Corp

This indicator synchronizes the market value of Kamada Ltd. (KMDA) with expected earnings, converting daily capitalization fluctuations into future revenue equivalents to assess fundamental potential. By analyzing the firm's projected sales volume, an investor sees a reflection of the stable R&D pipeline of Kamada Ltd., where the smoothness of the curve confirms a systematic expansion of therapeutic indications for plasma proteins without sharp speculative spikes.

Analisis perusahaan pesaing

Volume dodolan mangsa ngarep perusahaan VRTX (Vertex)|ALNY (Alnylam Pharmaceuticals, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Insmed INSM|UTHR (United Therapeutics Corp.) - Pendapatan sing dikarepake perusahaan|BioMarin Pharmaceutical - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan BBIO (BridgeBio Pharma, Inc.)|BGM Group Corp (BGM) - Prakiraan pendapatan perusahaan|Cogent Biosciences Inc (COGT) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Xeris Biopharma Inc|KROS: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan arcturusrx.com (ARCT)|Volume dodolan mangsa ngarep perusahaan Eton Pharmaceuticals ETON|Prakiraan volume dodolan FULC (fulcrumtx.com)|Prakiraan volume dodolan Abeona ABEO|MREO - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan PLX (Protalix BioTherapeutics, Inc)|Pliant Therapeutics Inc (PLRX) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan APLT (appliedtherapeutics.com)|RNTX (Rein Therapeutics Inc.) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GELS|Volume dodolan mangsa ngarep perusahaan AYTU (aytubio.com)|Volume dodolan mangsa ngarep perusahaan Chemomab Therapeutics Ltd CMMB|Prakiraan volume dodolan SRXH (SRx Health Solutions Inc.)|Pendapatan mangsa ngarep perusahaan PLRZ|AEZS - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CYTH (CTD Holdings)|INZY: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan RPHM (Reneo Pharma)|Prakiraan pendapatan perusahaan cosciensbio.com